The annual JP Morgan Healthcare Conference in San Francisco is one of the largest and most informative healthcare investment symposiums in the industry. It brings together global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. Each year hundreds of companies, both public and private, deliver presentations to over 4,000 investors. In addition, thousands in biotech descend upon San Francisco to network, attend meetings and gain an inside view even if they can’t secure an official conference invite. With the Trump administration geared up to make some changes, what can we expect in 2019 in regard to drug pricing, the regulatory environment and capital markets. If you can’t make it to the conference, or if your role does not require you to attend the JP Morgan conference, join us for a recap of it and hear from a select group of Conference insiders.